In this Section |
174551 Single Visit Approach: An Approach to prevent Cervical Cancer in Karawang District, West Jawa, IndonesiaMonday, October 27, 2008
Cervical cancer in Indonesia is a serious problem whose impact is neither widely appreciated nor well documented. Existing services are expensive and out of reach of the average woman. There are only 277 pathologists and fewer than 100 cytotechnicians in the whole country (to serve an at risk female population of 55,500,000 million), which means that a Pap smear-only based program will never achieve sufficient coverage to make an impact on cervical cancer-related morbidity and mortality. The coverage rate in 2003 was a mere 3% (Indonesian Cancer Foundation).
With funding from Ford Foundation, JHPIEGO is providing technical assistance to the Indonesian Ministry of Health (MOH) to establish cervical cancer prevention services using Single Visit Approach (SVA) to screening with visual inspection with household vinegar (VIA) and cryotherapy. This approach is an evidence based effective method for detecting and treating precancer cervical lesions. It can be provided by trained midwifes, nurse or doctors. Since August 2007, the program has established services at 4 health centers (Puskesmas) in Karawang, and with the district hospital as the referral point To date, a total of 947 clients have been screened by puskesmas staff through the SVA, of which 31 were found to have precancerous lesions and 9 underwent cryotherapy treatment. Five women were found to have cancer and have been refer to Karawang District Hospital. SVA is an effective and low cost approach compared to other method. The Karawang District Health Office has requested funding from local government to scale up SVA for other Puskesmas within Karawang.
Learning Objectives: Keywords: Cervical Cancer, Women's Health
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am coordinator the project of SVA in Karawang, therefore I am qualified to be the author, since I am in contact with the provider, clients as well as the stakeholder related to this project. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: International Reproductive Health and Family Planning
See more of: Population, Family Planning, and Reproductive Health |